Chinese maker of pharmaceutical packaging materials, such as rubber stoppers, for injectable-drug packaging.
Chinese maker of pharmaceutical packaging materials, such as rubber stoppers, for injectable-drug packaging.
Moat: narrow (customer qualification, regulatory licence). Pharma-grade packaging materials require drug-regulatory qualification, creating switching costs.
Headquarters: Jiangsu, China · Employees: 945
Size Jiangsu Hualan New Pharmaceutical Material (301093.SZ) is a China Materials company (Containers/Packaging) with a market value of $1.35B, the 1662nd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥42.90 on 18 Nov 2026.
Performance Over six months the shares fell 45.6%, against -0.4% for the median peer and -20.0% for the China market (cap-weighted) — 3rd lowest of 21 in its peer set.
Growth Revenue grew 5.5% over the last twelve months (peer median +0.6%); the operating margin is 4.6% (peer median 7.8%).
Valuation It trades at 68.3× forward earnings against a peer median of 15.4× (2nd most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 48% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is +41 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 5.6 points below its cost of capital (10.9% WACC).
Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥638M | CN¥618M | CN¥584M | CN¥620M | CN¥581M |
| Revenue growth | — | +6% | -6% | +7% | — |
| Gross profit | CN¥302M | CN¥209M | CN¥195M | CN¥232M | CN¥233M |
| EBITDA | n/a | CN¥131M | CN¥108M | CN¥134M | CN¥120M |
| Net income | CN¥39.1M | CN¥60.2M | CN¥49.6M | CN¥118M | CN¥93.8M |
| Free cash flow | CN¥66.0M | CN¥8.01M | CN¥31.9M | -CN¥36.7M | -CN¥68.8M |
| Capital expenditure | CN¥98.8M | CN¥133M | CN¥135M | CN¥297M | CN¥174M |
| Total debt | CN¥228M | CN¥176M | CN¥59.9M | CN¥61.0M | CN¥49.0M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Jiangsu Hualan New Pharmaceutical Material 301093.SZ | $1.35B | -46% | +6% | 5% | 68.3× | 47.9% |
| West Pharmaceutical Services WST | $28.1B | +32% | +13% | 23% | 40.2× | 25.8% |
| Shandong Pharmaceutical Glass 600529.SS | $1.78B | +1% | -9% | 18% | 16.4× | -3.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301093.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -18.5% | -1.6% | 2nd lowest of 21 |
| 6-month return | -45.6% | -0.4% | 3rd lowest of 21 |
| Distance from 52-week high | -61.1% | -25.0% | 3rd lowest of 21 |
| Revenue growth (TTM) | +5.5% | +0.6% | 8th highest of 21 |
| Operating margin | 4.6% | 7.8% | 6th lowest of 21 |
| Forward P/E | 68.3× | 15.4× | 2nd most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 47.9% | -1.0% | 2nd most demanding of 12 |
| Growth delivered (Del g) | +6.7% | +6.6% | 6th highest of 12 |
| Hurdle (Req g minus delivered) | +41.2 pp | -4.0 pp | 3rd most demanding of 12 |
| ROIC minus cost of capital | -5.6 pp | -0.6 pp | 5th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jiangsu Hualan New Pharmaceutical Material 301093.SZ | China | $1.35B | -46% | +6% | 5% | 68.3× | 47.9% | +6.7% |
| TriMas TRS | United States | $1.34B | -3% | -33% | 4% | 19.0× | n/a | n/a |
| Orora ORA.AX | Australia | $1.30B | +21% | +6% | 11% | 15.4× | 2.6% | -8.9% |
| Jiamei Food Packaging (Chuzhou) 002969.SZ | China | $1.41B | -63% | -10% | 6% | 78.2× | 20.5% | +7.3% |
| Shanghai Shunho New Materials Technology 002565.SZ | China | $1.30B | -55% | -15% | -3% | n/a | n/a | n/a |
| Gerresheimer GXI.DE | Germany | $1.26B | +21% | +9% | -4% | 16.0× | 57.0% | +10.3% |
| Fuji Seal International 7864.T | Japan | $1.19B | +31% | +7% | 9% | 11.0× | n/a | n/a |
| Shenzhen Leaguer 002243.SZ | China | $1.17B | -26% | +5% | -3% | 18.5× | 43.3% | +1.6% |
| Zhejiang Great Shengda Packing 603687.SS | China | $1.16B | -2% | +1% | 3% | 38.1× | n/a | n/a |
| Shanghai Zijiang Enterprise 600210.SS | China | $1.59B | +3% | -18% | 10% | 11.6× | n/a | n/a |
| ORG Technology 002701.SZ | China | $1.62B | -20% | +24% | 5% | 10.2× | -5.3% | +15.8% |
| Shenzhen Changhong Technology 300151.SZ | China | $1.12B | -26% | -1% | 6% | 54.7× | n/a | n/a |
| Taiwan Hon Chuan Enterprise 9939.TW | Taiwan | $1.07B | -6% | +1% | 15% | 9.7× | -4.0% | +8.3% |
| Cascades CAS.TO | Canada | $1.07B | +45% | 0% | 5% | 8.7× | -1.0% | +3.1% |
| Huangshan Novel 002014.SZ | China | $1.04B | +4% | +9% | 12% | 16.2× | n/a | n/a |
| Shandong Pharmaceutical Glass 600529.SS | China | $1.78B | +1% | -9% | 18% | 16.4× | -3.0% | +5.5% |
| Elopak ELO.OL | Norway | $1.01B | +8% | 0% | 9% | 12.2× | -7.7% | +7.7% |
| Time Technoplast TIMETECHNO.NS | India | $1.00B | +10% | +21% | 11% | 12.1× | n/a | n/a |
| Suzhou Hycan 002787.SZ | China | $996M | -40% | 0% | 7% | 33.2× | n/a | n/a |
| Winpak WPK.TO | Canada | $1.86B | +14% | +3% | 15% | 12.4× | -10.6% | +6.6% |
| Zhejiang Zhongxin Environmental Protection Technology 603091.SS | China | $927M | -28% | +31% | 22% | 13.8× | 6.8% | +4.4% |